Self-Management Task Performance and Its Association with Biomarkers in Elderly Patients with Chronic Heart Failure:

Haixiang Zhu1, Xiaoxue Han1, Jinxuan Chen1

  • 1Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.

PubMed

Insights

Poor self-management in elderly heart failure patients is linked to higher levels of NT-proBNP and uric acid. Improving self-care skills, especially medication management, is crucial for better outcomes in chronic heart failure (CHF).

Area of Science:

  • Cardiology
  • Geriatrics
  • Biomarkers

Background:

  • Chronic heart failure (CHF) management in the elderly requires effective self-care.
  • Biomarkers like NT-proBNP and uric acid can reflect disease severity in CHF.

Purpose of the Study:

  • To investigate the relationship between self-management task performance and heart failure biomarkers (NT-proBNP, uric acid) in elderly CHF patients.
  • To explore the mediating role of disease severity in this association.

Main Methods:

  • Cross-sectional study of 103 elderly CHF patients.
  • Self-management task performance assessed using a six-task scale.
  • Analysis included partial correlation, logistic regression, and restricted cubic spline analysis.

Main Results:

  • Lower self-management task performance correlated with higher NT-proBNP and uric acid levels.
  • Higher performance was associated with younger age and lower biomarker levels.
  • Medication tasks had the lowest success rates; oedema and diet tasks had higher rates.

Conclusions:

  • Reduced self-management performance in elderly CHF patients is linked to elevated NT-proBNP and uric acid, indicating advanced disease.
  • Interventions targeting self-management, particularly medication adherence, are vital for improving patient outcomes.
  • Further research is needed on the long-term impact of enhanced self-management skills.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261